The correlation of maximal drug dose, tumor recruitment, and sequence timing with therapeutic advantage: schedule-dependent toxicity of cytosine arabinoside.
D000818:Animals; D003561:Cytarabine / Q000008:administration & dosage* / Q000633:toxicity; D004334:Drug Administration Schedule; D005260:Female; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats
D003561:Cytarabine